NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Women's Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Breast Cancer



Studies from Y.F. Huang and co-researchers yield new data on breast cancer



June 4th, 2009

"CYP1B1 is a key enzyme involved in estrogen metabolism and may Play an important role in the development and progression of breast cancer. In a population-based case-control study, we examined eight CYP1B1 haplotype-tagging single nucleotide polymorphisms in relation to invasive breast cancer risk," scientists writing in the journal Cancer Epidemiology Biomarkers & Prevention report.

"Analyses were based on 1,655 cases and 1,470 controls; all women were Caucasian. Among the individual single nucleotide polymorphisms, one (rs9341266) was associated with increased risk of breast cancer P-trend = 0.021), although the association was no longer significant after...


Source: Women's Health Weekly (2009-06-04)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login